UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 11, 2025
Accession Number:
0001193125-25-051435
Submission Type:
POS AM
CIK:
0001830749
Company Name:
Achilles Therapeutics plc
File Number:
333-268239